Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,806,849
-
Total 13F shares
-
72,777,604
-
Share change
-
+36,485,527
-
Total reported value
-
$110,698,611
-
Put/Call ratio
-
22%
-
Price per share
-
$1.52
-
Number of holders
-
85
-
Value change
-
+$55,724,802
-
Number of buys
-
50
-
Number of sells
-
58
Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2025
As of 30 Jun 2025,
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,777,604 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., T. Rowe Price Investment Management, Inc., JENNISON ASSOCIATES LLC, Cormorant Asset Management, LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC, HEIGHTS CAPITAL MANAGEMENT, INC, PRICE T ROWE ASSOCIATES INC /MD/, and Jefferies Financial Group Inc..
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.